Colombia vs Greece: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Colombia
89.0%
in 2025
Greece
89.0%
in 2025
Colombia rank
72nd
Greece rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Colombia
- Greece
How they compare
Colombia currently reports 89.0% against 89.0% in Greece, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Greece ahead.
Colombia ranks 72nd and Greece ranks 72nd of 194 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Greece in 1.
Head to head by decade
| Decade | Colombia | Greece | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 78.6% | 64.0% | 14.6% | Colombia |
| 2020s | 88.0% | 92.3% | 4.3% | Greece |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Colombia or Greece?
- Colombia, at 89.0% against 89.0% in Greece as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Colombia and Greece?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Greece?
- 18 years are reported by both, from 2008 to 2025.
- How do Colombia and Greece rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Colombia ranks 72nd and Greece ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.